Prognostic value of angiopoietin-2 in patients with chronic heart failure

Eleuteri Ermanno; Di Stefano Antonino; Giordano Andrea; Corra Ugo; Genta Franco Tarro; Gnemmi Isabella; Giannuzzi Pantaleo

首页> 外文期刊>International Journal of Cardiology >Prognostic value of angiopoietin-2 in patients with chronic heart failure

【24h】

Prognostic value of angiopoietin-2 in patients with chronic heart failure

机译：血管生成素2在慢性心力衰竭患者中的预后价值

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Purpose The analysis of biomarkers with a prognostic value in chronic heart failure (CHI) is in constant progress. This study aimed to evaluate the short-term prognostic value of angiopoietin-2 (Ang2), galectin-3 (Gal-3), myeloperoxidase (MPO), endostatin (End), and pro-brain natriuretic peptide (pro-BNP) as a conventionally accepted prognosis biomarker in CHI patients.

机译：目的对具有慢性心力衰竭（CHI）预后价值的生物标志物的分析一直在不断进行。本研究旨在评估血管生成素2（Ang2），半乳凝素3（Gal-3），髓过氧化物酶（MPO），内皮抑素（End）和前脑利钠肽（pro-BNP）的短期预后价值CHI患者中常规接受的预后生物标志物。

著录项

来源
《International Journal of Cardiology》 |2016年第null期|共5页
作者
Eleuteri Ermanno; Di Stefano Antonino; Giordano Andrea; Corra Ugo; Genta Franco Tarro; Gnemmi Isabella; Giannuzzi Pantaleo;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类
关键词
Heart failure; Biomarkers; Angiopoietin-2; Galectin-3; Myeloperoxidase; Pro-BNP;

机译：心力衰竭;生物标志物;血管生成素-2;Galectin-3;髓过氧化物酶;Pro-BNP;

相似文献

外文文献
中文文献
专利

1. Prognostic value of angiopoietin-2 in patients with chronic heart failure [J] . Eleuteri Ermanno, Di Stefano Antonino, Giordano Andrea, International Journal of Cardiology . 2016,第Null期

机译：血管生成素2在慢性心力衰竭患者中的预后价值
2. Body surface area as a prognostic marker in chronic heart failure patients: results from the Heart Failure Registry of the Heart Failure Association of the European Society of Cardiology [J] . Zafrir Barak, Salman Nabeeh, Crespo-Leiro Maria G., European journal of heart failure: journal of the Working Group on Heart Failure of the European Society of Cardiology . 2017,第3期

机译：体表面积作为慢性心力衰竭患者的预后标志物：欧洲心脏病学会心力衰竭协会的心力衰竭注册表结果
3. Body surface area as a prognostic marker in chronic heart failure patients: results from the Heart Failure Registry of the Heart Failure Association of the European Society of Cardiology [J] . Zafrir Barak, Salman Nabeeh, Crespo-Leiro Maria G., European journal of heart failure: journal of the Working Group on Heart Failure of the European Society of Cardiology . 2016,第7期

机译：体表面积作为慢性心力衰竭患者的预后标志：欧洲心脏病学会心力衰竭协会心力衰竭登记处的结果
4. Prognostic value of non invasive baroreflex sensitivity in chronic heart failure patients [C] . Maestri, R., Pinna, . 2001

机译：无创压力反射敏感性在慢性心力衰竭患者中的预后价值
5. The Relationship Between Chronotropic Incompetence and Exercise Response in Patients with Chronic Heart Failure with Reduced Ejection Fraction [D] . Tinsley, Emily A. 2020

机译：慢性心力衰竭患者慢性心力衰竭减少射血分数的关系与慢性心力衰竭的关系
6. Apelin Improves Prognostic Value of HFSS (Heart Failure Survival Score) and MAGGIC (Meta-Analysis Global Group in Chronic Heart Failure) Scales in Ambulatory Patients with End-Stage Heart Failure [O] . Wioletta Szczurek, Mariusz Gąsior, Michał Skrzypek, 2020

机译：Apelin改善了HFSS（心力衰竭生存率）和玛吉的预后值（Meta-Analyall Global Grate Group）在终级心力衰竭患者的动态患者中的鳞片
7. P1246Age-, body size-, and sex-specific reference values for tricuspid valve apparatus parameters by real-time three-dimensional transthoracic echocardiographyP1247Surgical therapy in infective endocarditis: predisposing and prognostic factorsP1248Evalutation of MV annulus geometry modifications before and after mitraclip implantation with 3D transesophageal echocardiographyP1249Prognostic echocardiographic parameters for successful transcatheter edge-to-edge mitral valve repairP1250Influence of body surface area in diagnosis and outcome patient-prosthesis mismatch after TAVI. Is it necessary to adjust for ideal body weight?P1251Outcome of paradoxical low-flow low-gradient severe AS following TAVI: paradoxical VS parallel to outcome of high gradient ASP1252Prognostic role of cardiac calcifications in subjects without overt significant heart disease and previous cardiovascular events: is there an additive value over cardiovascular risk factors scores?P1253Aging degeneration of mitral valve without leaflet prolapse or tethering as a cause of severe mitral regurgitationP1254Cardiovascular risk assessment should be performed in patients with incidental aortic sclerosisP1255Cardiac valve calcification score: simple 2D echocardiographic tool for cardiovascular risk stratification in patients with chronic renal failureP1256Diastolic mitral regurgitation following transcatheter aortic valve replacement: prevalence, predictors and impact on outcomesP1257Timing of myocardial shortening determines left ventricular regional remodelling in hearts with conduction delaysP1258Myocardial stiffness assessment using shear wave imaging in healthy children and hypertrophic cardiomyopathyP1259Assessment of right ventricular response to exercise using vector velocity imaging in hypertrophic cardiomyopathyP1260Diagnostic value of cardiac biomarkers (high sensitive troponin T and N-terminal pro-brain natriuretic peptide) in patients with infiltrative cardiomyopathiesP1261Right ventricular global longitudinal strain differentiates between adolescent patients with definite, borderline and possible ARVC and controlsP1262 echogrqphic predictif factors of atrial arrhythmias in patients with arrhythmogenic right ventricular dysplasiaP1263Importance of combined left atrial size and estimated pulmonary pressure for clinical outcome in patients presenting with heart failure with preserved ejection fractionP1264Chronotropic response in mitochondrial (ANT1) cardiomyopathyP1265 The effect of cardiovascular risk factors and cancer type in anthracycline's cardiotoxicityP1266Revisiting the echocardiographic features of acute myocarditisP1267Altered circulation in fetuses of diabetic mothers: a fetal computational model analysisP1268Increased epicardial adipose tissue is related to stress-induced cardiomyopathyP1269Contrast enhanced ultrasound of kidney perfusion in patients with renal artery stenosis: diagnostic and prognostic applications. [O] . F. Ancona, R. Ilhao Moreira, V. Lavanco, 2016

机译：P1246age-，身体大小和性别特异性参考Tricuspid阀装置参数通过实时三维经线性超声心动图124772777777747774747478EVALIGUTALMEXP1249预期植入前后MV环形植入前后MV环空性修饰。超声心动图参数用于成功的经截管边缘到边缘二尖瓣修复P1250中的体表面积诊断和结果患者假体在Tavi后的不匹配。是否有必要调整理想的体重？P1251矛盾的低流量低梯度严重，如Tavi：矛盾的VS平行于高梯度ASP1252的结果，在没有明显显着的心脏病和以前心血管事件的情况下心脏钙化的促傲作用患有心血管危险因素的添加剂值分数？没有传单脱垂的二尖瓣退化或作为严重二尖瓣血管血管血管病风险评估的患者进行脱垂或系绳，应当在偶然主动脉源肺源P1255Cariac阀钙化评分患者中进行：用于心血管风险分层的简单2D超声心动图工具在慢性肾功能衰竭的患者中，经沟管主动脉瓣膜置换术后：流行率，预测因子和对Otcomasp1257的影响，心肌缩短决定了导通延迟的心中的剩余心室区域重新耦合258MYCIARIAL僵硬评估使用剪切波成像在健康儿童和肥厚性心肌脑病中的舒缓性心脏响应，在渗透心肌肌瘤患者中使用载体速度成像的培养速度成像（高敏感的肌钙蛋白T和N-末端脑Natrietic肽）渗透心肌病，患者心室全局纵向菌株在患有心律失常右心室发育不良患者的心理心律失常患者中的青少年患者与Controlsp1262 echogrqphic预测因子的分歧，患者心血性右心室发育不良患者患者患者患者患者患者患者患者患者患者线粒体（ANT1）心肌病患者的喷射FRACTIONP1264系列响应1265心血管危险因素和癌症类型在蒽丙烯的心肌毒性皮1126660中的影响访问患有糖尿病母亲胎儿胎儿急性心肌炎的超声心动图，患者患者：胎儿计算模型分析P1268增加外膜脂肪组织与肾动脉狭窄患者肾脏灌注的应激诱导的心肌病，增强超声波：诊断和预后应用。

Prognostic value of angiopoietin-2 in patients with chronic heart failure

摘要

著录项

相似文献

相关主题

期刊订阅